Company Filing History:
Years Active: 2021-2025
Title: Christopher Magnus: Innovator in Ligand-Gated Ion Channels
Introduction
Christopher Magnus is a prominent inventor based in Chevy Chase, MD (US). He has made significant contributions to the field of biochemistry, particularly in the development of modified ligand-gated ion channels. With a total of 5 patents, his work has the potential to impact various medical applications.
Latest Patents
One of his latest patents focuses on "Modified ligand-gated ion channels and methods of use." This document relates to materials and methods for modulating ligand-gated ion channel (LGIC) activity. It includes modified LGICs that feature at least one LGIC subunit with a modified ligand binding domain (LBD) and/or a modified ion pore domain (IPD). Additionally, the patent provides exogenous LGIC ligands that can bind to and activate the modified LGIC. The methods outlined in this patent aim to modulate ion transport across the membrane of a mammal's cell, enhance the excitability of a cell, and treat channelopathies in mammals.
Career Highlights
Christopher Magnus is affiliated with the Howard Hughes Medical Institute, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in treating various medical conditions related to ion channel dysfunction.
Collaborations
Some of his notable coworkers include Scott Sternson and Peter Lee, who have collaborated with him on various projects related to ligand-gated ion channels.
Conclusion
Christopher Magnus is a key figure in the field of biochemistry, with a focus on ligand-gated ion channels. His innovative patents and collaborations highlight his commitment to advancing medical science.